Search Ontology:
ChEBI

orteronel

Term ID
CHEBI:231353
Synonyms
  • (+)-orteronel
  • (S)-orteronel
  • 6-[(7S)-7-hydroxy-6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-7-yl]-N-methylnaphthalene-2-carboxamide
  • orteronel
  • orteronelum
  • TAK 700
  • TAK-700
  • TAK700
Definition
A member of the class of pyrroloimidazoles that is 6,7-dihydro-5H-pyrrolo[1,2-c]imidazole substituted by hydroxy and 6-(methylcarbamoyl)naphthalen-2-yl groups at position 7 (the 7S-stereoisomer). It is a non-steroidal 17,20-lyase inhibitor that suppresses androgen synthesis. It was previously in clinical development for the treatment of castration-resistant prostate cancer — trial now discontinued.
References
  • cas:566939-85-3
  • drugbank:DB12066
  • kegg.drug:D10146
  • pdb-ccd:7D6
  • pmc:PMC4185570
  • pmc:PMC4218005
  • pubmed:21978946
  • pubmed:22249003
  • pubmed:22714983
  • pubmed:22793031
  • pubmed:23146910
  • pubmed:23788266
  • pubmed:23856460
  • pubmed:24418642
  • pubmed:24965748
  • pubmed:25556680
  • pubmed:25624429
  • pubmed:26382777
  • pubmed:26418412
  • pubmed:27046420
  • pubmed:27163496
  • pubmed:27163497
  • pubmed:27482286
  • pubmed:28373265
  • pubmed:28427507
  • pubmed:31072872
  • pubmed:32223238
  • pubmed:34273352
  • pubmed:34824002
  • pubmed:35250590
  • pubmed:35446628
  • pubmed:37085425
  • pubmed:37745904
  • pubmed:38424319
  • pubmed:38523017
  • wikipedia.en:Orteronel
Ontology
ChEBI  ( EBI )
Relationships
Phenotype
Phenotype resulting from orteronel
Phenotype where environments contain orteronel
Phenotype modified by environments containing orteronel
Phenotype affecting orteronel
Human Disease Model